Article Text

This article has a correction. Please see:

Download PDFPDF
Malaria vaccine: promising results

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Over 780 million people, mostly children in Africa, die of malaria each year. Although malaria control measures such as insecticide-treated bed nets, insecticides and artemisinin-combination treatments, have resulted in reduced malaria morbidity and mortality in some countries, an effective vaccine is badly needed. The RTS,S vaccine targets the circumsporozoite protein. It is given with an adjuvant system (AS01 or AS02) and has shown efficacy in phase 2 trials. Now the initial results of a phase 3 trial in …

View Full Text


  • Competing interests None.

  • Provenance and peer review Commissioned; internally peer reviewed.

Linked Articles

  • Miscellanea
    BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health